Maternal and Perinatal Outcomes in Oligohydramnios at or Beyond 34 Weeks of Gestation: A Prospective Case–Control

Abstract Oligohydramnios is associated with increased obstetric interventions and adverse perinatal outcomes. Recent global and regional studies confirm these risks even in borderline cases. Methods: A prospective case–control study including 100 cases (AFI ≤5 cm) and 100 controls (AFI >5 cm) at ≥34 weeks, excluding PROM, anomalies, and multiple gestation. Outcomes: induction, non-reactive NST, meconium-stained liquor, cesarean, low birth weight, NICU admission, and perinatal morbidity/mortality. Statistical significance at p<0.05. Results: Induction rate was 45% vs 29% (p=0.019); non-reactive NST 36% vs 15% (p<0.001); meconium-stained liquor 43% vs 23% (p=0.003); cesarean delivery 54% vs 39% (p=0.033); LBW 50% vs 22% (p<0.001); 5-min Apgar <7 74% vs 39% (p<0.001); NICU stay >15 days 15% vs 5% (p=0.018). Conclusion: Oligohydramnios at ≥34 weeks significantly increases maternal interventions and neonatal morbidity. Vigilant monitoring and timely intervention are essential.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-09-30
DOI
https://doi.org/10.5281/zenodo.18093061
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Maternal and Perinatal Outcomes in Oligohydramnios at or Beyond 34 Weeks of Gestation: A Prospective Case–Control

International Journal of Medical Science and Innovative Research (IJMSIR)
Zenodo (CERN European Organization for Nuclear Research)
Pregnancy and preeclampsia studies
article

Maternal and Perinatal Outcomes in Oligohydramnios at or Beyond 34 Weeks of Gestation: A Prospective Case–Control

International Journal of Medical Science and Innovative Research (IJMSIR)
article en

Abstract

Abstract Oligohydramnios is associated with increased obstetric interventions and adverse perinatal outcomes. Recent global and regional studies confirm these risks even in borderline cases. Methods: A prospective case–control study including 100 cases (AFI ≤5 cm) and 100 controls (AFI >5 cm) at ≥34 weeks, excluding PROM, anomalies, and multiple gestation. Outcomes: induction, non-reactive NST, meconium-stained liquor, cesarean, low birth weight, NICU admission, and perinatal morbidity/mortality. Statistical significance at p<0.05. Results: Induction rate was 45% vs 29% (p=0.019); non-reactive NST 36% vs 15% (p<0.001); meconium-stained liquor 43% vs 23% (p=0.003); cesarean delivery 54% vs 39% (p=0.033); LBW 50% vs 22% (p<0.001); 5-min Apgar <7 74% vs 39% (p<0.001); NICU stay >15 days 15% vs 5% (p=0.018). Conclusion: Oligohydramnios at ≥34 weeks significantly increases maternal interventions and neonatal morbidity. Vigilant monitoring and timely intervention are essential.

Zenodo (CERN European Organization for Nuclear Research)
Innovative Research (United States) (US)
Good health and well-being
Openalex Percentile: Top 25%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Maternal and Perinatal Outcomes in Oligohydramnios at or Beyond 34 Weeks of Gestation: A Prospective Case–Control — International Journal of Medical Science and Innovative Research (IJMSIR) · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS